Detalles de la búsqueda
1.
Shifting risk-stratified early prostate cancer detection to a primary healthcare setting.
BJU Int
; 131(5): 596-601, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36408660
2.
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Int J Mol Sci
; 22(6)2021 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33799514
3.
Additional benefit of using a risk-based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
BJU Int
; 120(3): 394-400, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28498624
4.
Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
BJU Int
; 120(4): 511-519, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28267899
5.
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.
Int J Urol
; 24(4): 281-286, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28173626
6.
Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study.
BJU Int
; 118(3): 366-71, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26765682
7.
Prostate-specific antigen-based prostate cancer screening: Past and future.
Int J Urol
; 22(6): 524-32, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25847604
8.
Is transrectal ultrasonography of the prostate obsolete in the MRI era?
BJU Int
; 123(3): 377-378, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30821097
9.
Editorial Comment to Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.
Int J Urol
; 25(3): 277, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29569775
10.
Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator.
Transl Androl Urol
; 12(2): 241-248, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915892
11.
Distribution of Prostate Imaging Reporting and Data System score and diagnostic accuracy of magnetic resonance imaging-targeted biopsy: comparison of an Asian and European cohort.
Prostate Int
; 7(3): 96-101, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31485433
12.
Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Eur Urol
; 75(2): 310-318, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30082150
13.
Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.
Transl Androl Urol
; 7(1): 27-33, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29594017
14.
Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic Resonance Imaging?
Eur Urol
; 73(3): 343-350, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28647216
15.
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Eur Urol
; 69(6): 1129-34, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26651990
16.
[Guidelines on the early detection of prostate cancer]. / Richtlijnen voor vroegdiagnostiek van prostaatkanker.
Ned Tijdschr Geneeskd
; 159: A8811, 2015.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-25898869
17.
Targeted therapies in bladder cancer: an overview of in vivo research.
Nat Rev Urol
; 12(12): 681-94, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26390971
18.
Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.
Eur Urol
; 68(5): 814-21, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26138043
Resultados
1 -
18
de 18
1
Próxima >
>>